Global Space Infrastructure Leader Redwire to Build State-of-the-Art Microgravity Payload Development and Space Operations Facility in Floyd County, Indiana

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, will be opening a new state-of-the-art microgravity payload development facility with a mission operations center at the Novaparke Innovation & Technology Campus in Floyd County, Indiana. The company looks to increase production of critical technologies enabling human spaceflight missions and commercial microgravity research and development in low-Earth orbit (LEO).

The new 30,000 square foot facility will support increased demand from commercial companies and academic researchers focused on improving pharmaceutical drug development, optimizing disease treatments, and enabling technologies essential for sustainable human spaceflight in LEO and beyond. Groundbreaking took place in May 2024. Construction is expected to be completed in approximately 15 months.

“Redwire’s continued investment in Indiana is a testament to our shared commitment to building a robust economy of the future,” said David Watkins, senior vice president of small business and entrepreneurship at the Indiana Economic Development Corporation (IEDC). “These new high-wage, high-skill careers will provide greater opportunities for residents of Floyd County and help further position Indiana as a leader in innovation.”

“We are building capacity as we pioneer consequential in-space manufacturing and microgravity research capabilities, such as bioprinting, in low-Earth orbit, with life-saving benefits on and off our home planet,” said John Vellinger, Redwire Executive Vice President. “As we leverage strategic investments to scale in-space manufacturing in LEO, it will directly impact the sustainability of future human spaceflight and deliver optimized products for Earth-based industries. The new facility will help accelerate the development of our growing portfolio of new microgravity research technologies, such as biomedical research payloads, as we continue to serve our research and deep space exploration customers.”